ApoB adds the count of cholesterol-carrying particles to your standard LDL profile. Measure ApoB plus 9 more blood values from home. Nearly painless upper-arm sample, certified lab. €99, no subscription.
In “discordance” studies - people whose LDL-C and ApoB point in different directions - long-term cardiovascular risk tracked the ApoB particle count, not the cholesterol weight.
LDL-C weighs the cholesterol; ApoB counts the particles carrying it. The 2019 ESC/EAS guideline notes that ApoB, where available, can be used as an alternative to LDL-C as the primary measurement for risk assessment.
Both panels carry the same total LDL cholesterol - 130 mg/dL. What differs is how it is packaged. More particles, smaller particles, higher chance of one slipping into an artery wall.
Same cholesterol weight is packaged into fewer, larger particles. Lower particle count, lower lifetime risk.
The same cholesterol is split across many more particles. Higher particle count, more chances to lodge in an artery wall, higher risk.
Illustrative diagram - particle sizes and counts are stylised for clarity. The point is the relationship: LDL-C reports total weight, ApoB reports the number of particles carrying that weight.
Ranges differ between European, American and national guidelines. Below is the framework most cardiology guidelines now use for primary prevention.
Associated with the lowest long-term cardiovascular risk in current guideline frameworks. Lower targets apply for people with established disease.
Worth a conversation. Lifestyle change can often bring this back into range; medication is sometimes warranted.
Clinically meaningful elevation. A physician conversation is the right next step, regardless of LDL-C value.
Reference ranges are guidance, not diagnosis. Your CHIRAYOU report uses the range reported by the analysing laboratory and should be interpreted alongside your other markers and personal history.
ApoB tells you how many atherogenic particles are circulating - but cardiovascular risk is rarely driven by one number. Inflammation and kidney function both shape the bigger picture. That is why CHIRAYOU measures ApoB plus 9 more blood values, so your result sits in context.

A sensitive marker for the silent, low-grade inflammation that drives plaque alongside ApoB.

Kidney function is tightly linked to long-term cardiovascular risk.
ApoB, inflammation and kidney function belong together for a real risk picture. Explore the full panel:
A standalone ApoB test gives you one number to interpret yourself. The CHIRAYOU baseline test measures ApoB plus 9 more blood values - collected with a nearly painless upper-arm device and read together, using a physician-developed protocol.
You get your ApoB value either way - analysed in a certified lab and explained in plain language. CHIRAYOU simply isn't a single-marker test: from the same sample you also get ApoB plus 9 more blood values at one flat price - so you understand your cardiovascular risk in context, not as an isolated number.
ApoB plus 9 more blood values from a single sample. ApoB is highlighted here - the other markers provide the context.
No vein needle. No appointment. No waiting room. Less than ten minutes from your couch.

Tasso+ device, step-by-step instructions and a prepaid return envelope. Free shipping, nothing else to buy.

A gentle vacuum draws a few drops of capillary blood into a small tube. No vein needle, no finger prick - most people barely feel it.

The envelope is addressed and postage-paid. Your sample goes straight to Limbach Gruppe, a DAkkS-accredited German lab.

ApoB plus 9 more blood values, each set against its reference range - with context and recommended next steps.

The Tasso+, in short: fits in your palm and sticks on like a patch · one button, a gentle vacuum fills the tube · no lancet, no needle in a vein
The convenience does not come from a softer lab. It comes from cutting out the clinic visit - not the rigor behind the result.

“My goal is to slow aging and support a healthy, radiant appearance. Healthy aging means a state in which the number of healthy, active years comes as close as possible to the biological lifespan.”
Approbiert in Germany. Results that fall clearly outside the reference range are flagged in your app with a recommendation to consult your GP. For a personal physician review on each result, see the CHIRAYOU Program.

Your sample is analysed by Limbach Gruppe, one of Germany's largest medical laboratory networks - the same accreditation a clinic venous draw uses. Validated stability window for at-home capillary samples in transit.
Too little blood, damaged in transit, missed the stability window? We send a new kit. You do not pay again.
The CHIRAYOU test includes everything you need: at-home kit, upper-arm Tasso+ collection, lab analysis, ApoB plus 9 more blood values, a digital report, and interpretation built on a physician-developed protocol.

Optional doctor consultation. Prefer to go through your results with a physician? Add an optional 20-minute video consultation at checkout (+€50).
Secure payment via Stripe · Free shipping to you & back to the lab
Per blood value, a fraction of a single vitamin D lab test (~€40) - 10 lab-analyzed values from one sample.
See the full cost breakdownShort, direct answers - and where the source-level detail lives if you want to go deeper.
10 blood values including ApoB, hsCRP and eGFR. Collected at home, analysed in a certified German lab.